Gentris Corporation

Gentris Corporation is a global provider of pharmacogenomic testing and biorepository services. As a pioneer in the field, Gentris assists pharmaceutical companies and clinical research organizations in effectively integrating pharmacogenomics into their drug development programs to bring safer and more effective compounds to market more quickly. By better characterizing patient populations, pharmacogenomics can help drug companies modify patients' drug exposure based on their genomic drug response profiles, thereby helping to reduce drug failure rates. This ensures that the right drug reaches the right patient at the correct dosage, providing optimal benefits based on their pharmacogenomic profile.